Trademark: INHIBIKASE
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for INHIBIKASE
We do not have any records of a proof of use for INHIBIKASE at this moment.
Possible trademark infringements of INHIBIKASE
Basic Information about INHIBIKASE
- Serial Number
- 88169711
- Filing Date
- 25 Oct 2018
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of INHIBIKASE on the blockchain with WikiTrademarks.io.
- First use of INHIBIKASE anywhere
- INHIBIKASE was first used on 31 Aug 2021 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns INHIBIKASE?
1. Inhibikase Therapeutics, Inc. Atlanta GA
2. Inhibikase Therapeutics, Inc. Atlanta GA
Correspondent
- Howard J. Shire
- Troutman Pepper Hamilton Sanders LLP
- THE NEW YORK TIMES BUILDING
- 620 EIGHTH AVENUE
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io